Calendar Edwards Lifesciences Corporation
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85.73 USD | -2.40% |
|
-7.03% | +0.56% |
| 07-16 | Truist Adjusts Price Target on Edwards Lifesciences to $95 From $90, Maintains Hold Rating | MT |
| 07-16 | Abbott raises 2026 profit forecast on heart device strength | RE |
Chart calendar Edwards Lifesciences Corporation
Upcoming events on Edwards Lifesciences Corporation
| 24/07/2026 | Earnings presentation | 05:00 |
| 24/07/2026 | Earnings release - Q2 2026 |
Past events on Edwards Lifesciences Corporation
| 08/05/2026 | Présentation aux Actionnaires / Analystes | 01:00 |
| 08/05/2026 | Annual General Meeting | 01:00 |
| 24/04/2026 | Earnings presentation | 05:00 |
| 24/04/2026 | Earnings release - Q1 2026 | |
| 11/02/2026 | Earnings presentation | 06:00 |
| 11/02/2026 | Earnings release - Q4 2025 | |
| 04/12/2025 | Analyst/Investor Day | 21:30 |
| 31/10/2025 | Earnings presentation | 05:00 |
| 31/10/2025 | Earnings release - Q3 2025 | |
| 25/07/2025 | Earnings release - Q2 2025 | |
| 25/07/2025 | Earnings presentation | 05:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6 005 5 972 0.55% | 5 440 5 902 -7.84% | 6 068 6 034 0.56% | 6 743 | 7 405 | 8 132 |
|
EBITDA Million USD | Released Forecast Spread | 1 879 1 904 -1.34% | 1 670 1 796 -7.03% | 1 800 1 825 -1.34% | 2 114 | 2 365 | 2 670 |
|
EBIT Million USD | Released Forecast Spread | 1 734 1 754 -1.15% | 1 515 1 654 -8.45% | 1 644 1 667 -1.44% | 1 956 | 2 190 | 2 456 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 598 1 658 -3.62% | 1 548 1 587 -2.46% | 1 273 1 684 -24.39% | 1 973 | 2 261 | 2 545 |
|
Net income Million USD | Released Forecast Spread | 1 402 1 399 0.22% | 4 175 1 382 202.01% | 1 074 1 327 -19.08% | 1 618 | 1 881 | 2 098 |
|
EPS USD | Released Forecast Spread | 2,30 2,29 0.34% | 6,97 2,31 202.06% | 1,83 2,26 -19.16% | 2,80 | 3,27 | 3,67 |
| Announcement Date | 06/02/24 | 11/02/25 | 10/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 354 1 368 -1.01% | 1 386 1 358 2.06% | 1 413 1 401 0.87% | 1 532 1 485 3.15% | 1 553 1 495 3.87% | 1 570 1 544 1.69% | 1 649 1 596 3.31% | 1 699 | 1 689 | 1 715 | 1 799 | 1 853 | 1 855 | 1 895 | 1 973 |
|
EBITDA Million USD | Released Forecast Spread | 460 419 9.86% | 397 385 3.2% | 448 424 5.55% | 471 444 6.04% | 466 422 10.34% | 415 442 -6.02% | 559 517 8.04% | 523 | 521 | 522 | 586 | 589 | 597 | 598 | |
|
EBIT Million USD | Released Forecast Spread | 426 376 13.22% | 355 350 1.48% | 411 384 7.21% | 433 407 6.23% | 427 389 9.76% | 373 400 -6.93% | 518 474 9.26% | 483 | 481 | 476 | 545 | 547 | 550 | 548 | 631 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 403 | 390 360 8.26% | 434 395 9.98% | 400 437 -8.41% | 348 404 -13.71% | 90,4 427 -78.82% | 459 491 -6.59% | 515 | 514 | 504 | 554 | 579 | 583 | 580 | 659 |
|
Net income Million USD | Released Forecast Spread | 3 071 340 804.32% | 386 315 22.55% | 358 331 8.16% | 333 360 -7.34% | 291 338 -13.8% | 91,2 338 -73.02% | 381 408 -6.72% | 417 | 416 | 415 | 461 | 475 | 479 | 480 | 545 |
|
EPS USD | Released Forecast Spread | 5,13 0,54 854.95% | 0,65 0,53 21.96% | 0,61 0,56 8.2% | 0,56 0,61 -8.2% | 0,50 0,57 -12.75% | 0,16 0,59 -72.94% | 0,66 0,71 -6.38% | 0,72 | 0,72 | 0,72 | 0,80 | 0,83 | 0,84 | 0,84 | 0,94 |
| Announcement Date | 24/10/24 | 11/02/25 | 23/04/25 | 24/07/25 | 30/10/25 | 10/02/26 | 23/04/26 | - | - | - | - | - | - | - | - |
| 20/07/2026 |  | Extraordinary General Meeting | 14:00 |
| 21/07/2026 | | Earnings presentation | 20:00 |
| 21/07/2026 | | Earnings release - Q2 2026 | 18:00 |
| 23/07/2026 | | Earnings presentation | 20:30 |
| 23/07/2026 | | Earnings release - Q2 2026 | |
| 23/07/2026 | | Extraordinary General Meeting | 14:00 |
| 24/07/2026 | | Ex-dividend date - 0.035 USD | 12:00 |
| 27/07/2026 | | Extraordinary General Meeting | 15:00 |
| 27/07/2026 | | Sales and Revenue Release - Q2 2026 | *E4DFANSWAPTOBAIJ22ORFMMWNCSDVOFTFBPAR |
| 28/07/2026 | | Earnings release - Q2 2026 |
Past sector events for Edwards Lifesciences Corporation
| 17/07/2026 | | Earnings release - Q2 2026 | |
| 17/07/2026 | | Earnings presentation | 04:30 |
| 17/07/2026 | | Ex-dividend date - 0.07 USD | 12:00 |
| 13/07/2026 | | Sales and Revenue Release - Q2 2026 | |
| 10/07/2026 | | Significant Split/Dividend | 12:00 |
| 10/07/2026 | | Ex-dividend date - 0.2 CNY | 12:00 |
| 10/07/2026 | | Significant Split/Dividend | 12:00 |
| 07/07/2026 | | Board of Directors Meeting | |
| 30/06/2026 | | Ex-dividend date - 0.255 USD | 12:00 |
| 30/06/2026 | | Annual General Meeting | 10:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- EW Stock
- Calendar Edwards Lifesciences Corporation
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition